Skip to main content
main-content

30-06-2019 | Alzheimer's disease | Video

EAN 2019: CSF alpha-synuclein discriminates Alzheimer’s disease from Lewy body dementia

José Antonio Monge-Argilés describes his study showing how alpha-synuclein levels can improve early differential diagnosis between progressive dementia types (3:13).

Funding for independent interviews at EAN 2019 was provided by F.Hoffmann-La Roche Ltd, Basel, Switzerland.

Image Credits